WLRK

Search
Search for:

The Firm
Attorneys
Practices
News and Publications
Careers
Contact

Home » Transactions » Pfizer/Upjohn – $4 billion revolving credit facility and $600 million delayed draw term loan facility in connection with the combination of Upjohn, a subsidiary of Pfizer, and Mylan in a Reverse Morris Trust transaction

Pfizer/Upjohn – $4 billion revolving credit facility and $600 million delayed draw term loan facility in connection with the combination of Upjohn, a subsidiary of Pfizer, and Mylan in a Reverse Morris Trust transaction

June 22, 2020

51 West 52nd Street, New York, NY 10019
t. 212.403.1000 or 800.848.0301 / Attorney Advertising and Other Notices

We are using cookies to give you the best experience on our website.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

Cookie Policy

More information about our Cookie Policy